<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>13</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2012</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>ABO Blood Group and Risk of Pancreatic Cancer in a Turkish Population in Western Blacksea Region</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>131</FirstPage>
			<LastPage>133</LastPage>
			<ELocationID EIdType="pii">26111</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>1970</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</History>
		<Abstract>&lt;b&gt;Background:&lt;/b&gt; We aimed to investigate the relationship between blood groups and pancreatic cancer in aTurkish population in Western Blacksea region. &lt;br/&gt;&lt;b&gt;Methods&lt;/b&gt;: This is a retrospective study. Zonguldak KaraelmasUniversity outpatient oncology clinic records were screened for the period between 2004 and 2011. &lt;br/&gt;&lt;b&gt;Results&lt;/b&gt;: Themedian age of patients were 56 (±16) and 132 of 633 study population had pancreatic cancer. Pancreatic cancerpatients had significantly higher rates of blood group A compared to controls (OR 1.8, 95%CI, p 0.005). Rates ofblood group AB was significantly lower than the control group (OR 0.37, 95% CI, p 0.04). The median survival(IR) time in subjects having the blood groups A, B, AB and O were 7.0 (1-28), 7.0 (2-38), 10 (2-36) and 9.0 (2-48)months respectively; the blood group 0 had significantly higher overall survival (OS) compared to the non-0groups (p 0.04). &lt;br/&gt;&lt;b&gt;Conclusions&lt;/b&gt;: Pancreatic cancer patients had more common blood group A in our population.Moreover, blood group AB appeared to be a protective factor against pancreatic cancer in our population. Bloodgroup 0 had a significantly longer survival compared to non-0, regardless of prognostic factors.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Blood group</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Pancreatic cancer</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">survival</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Turkey</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_26111_19adc8e8c84feca092ddf9d155876e90.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
